Mucoid exopolysaccharide vaccine against Pseudomonas aeruginosa
US4578458A · kind A · utility
36Cited by
1References
3Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 23, 1983 |
| Grant date | Mar 25, 1986 |
| Priority date | — |
| Expiry date | Mar 23, 2003 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/875
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of inducing an immune response against multiple strains of Pseudomonas aeruginosa which comprises administering to a human or animal an amount of mucoid exopolysaccharide from Pseudomonas aeruginosa 2192 sufficient to induce an immune response in the human or animal is disclosed along with the microorganism which produces this antigen and a method of separating the antigen from the crude bacterial slime.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.